Product
GnRH Antagonist
1 clinical trial
3 indications
Indication
In vitro fertilization (IVF)Indication
PPOSClinical trial
A Randomized Control Trial to Compare the Live Birth Rate Between the Progestin-primed Ovarian Stimulation Protocol and the GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Undergoing IVFStatus: Completed, Estimated PCD: 2022-10-10